HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+1.03%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$269M
AUM Growth
+$269M
(-7.3%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
168
New
26
Increased
41
Reduced
37
Closed
31
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$3.1M |
| 2 |
Guardant Health
GH
|
$2.88M |
| 3 |
Janux Therapeutics
JANX
|
$2.48M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$2.32M |
| 5 |
Dynavax Technologies
DVAX
|
$1.73M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$4.58M |
| 2 |
Capri Holdings
CPRI
|
$3.3M |
| 3 |
Amgen
AMGN
|
$3.25M |
| 4 |
Maplebear
CART
|
$3.2M |
| 5 |
GE Vernova
GEV
|
$2.6M |
Sector Composition
| 1 | Healthcare | 43.86% |
| 2 | Technology | 16.73% |
| 3 | Consumer Discretionary | 7.18% |
| 4 | Communication Services | 5.42% |
| 5 | Industrials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Enliven Therapeutics
ELVN
$1.24B
| $2.53M | 0.94% |
112,459
| – | – |
|
27
Alphabet (Google) Class C
GOOG
$2.79T
| $2.52M | 0.94% |
13,236
+700
| +6% | +$133K |
|
28
Revolution Medicines
RVMD
$7.43B
| $2.5M | 0.93% |
57,246
+1,684
| +3% | +$73.7K |
|
|
SWTX
29
DELISTED
SpringWorks Therapeutics
SWTX
| $2.48M | 0.92% |
68,758
+32,906
| +92% | +$1.19M |
|
30
Protagonist Therapeutics
PTGX
$3.62B
| $2.41M | 0.9% |
62,518
-26,990
| -30% | -$1.04M |
|
31
Liquidia Corp
LQDA
$2.52B
| $2.39M | 0.89% |
203,510
+22,563
| +12% | +$265K |
|
32
MoonLake Immunotherapeutics
MLTX
$3.78B
| $2.36M | 0.88% |
43,541
| – | – |
|
33
Merus
MRUS
$5.04B
| $2.31M | 0.86% |
55,039
-18,941
| -26% | -$796K |
|
|
34
GE Vernova
GEV
$157B
| $2.24M | 0.83% |
6,800
-7,900
| -54% | -$2.6M |
|
35
Teva Pharmaceuticals
TEVA
$21.5B
| $2.23M | 0.83% |
101,300
+16,200
| +19% | +$357K |
|
36
Spyre Therapeutics
SYRE
$1.02B
| $2.22M | 0.82% |
95,159
-10,192
| -10% | -$237K |
|
37
Edgewise Therapeutics
EWTX
$1.54B
| $2.21M | 0.82% |
82,732
-6,106
| -7% | -$163K |
|
38
Vera Therapeutics
VERA
$1.47B
| $2.21M | 0.82% |
52,197
+30,187
| +137% | +$1.28M |
|
39
TSMC
TSM
$1.2T
| $2.19M | 0.82% |
11,100
+800
| +8% | +$158K |
|
40
Cogent Biosciences
COGT
$1.83B
| $2.18M | 0.81% |
279,673
+54,040
| +24% | +$422K |
|
41
Broadcom
AVGO
$1.42T
| $2.11M | 0.78% |
9,100
+200
| +2% | +$46.4K |
|
42
Rhythm Pharmaceuticals
RYTM
$6.75B
| $2.1M | 0.78% |
37,426
| – | – |
|
43
Visa
V
$681B
| $2.03M | 0.76% |
6,427
-300
| -4% | -$94.8K |
|
44
Live Nation Entertainment
LYV
$37.6B
| $2.02M | 0.75% |
15,600
+1,200
| +8% | +$155K |
|
45
Apogee Therapeutics
APGE
$2.27B
| $1.96M | 0.73% |
43,190
-18,598
| -30% | -$842K |
|
46
Insmed
INSM
$30.3B
| $1.91M | 0.71% |
27,612
-17,835
| -39% | -$1.23M |
|
47
Dyne Therapeutics
DYN
$1.92B
| $1.85M | 0.69% |
78,420
+12,938
| +20% | +$305K |
|
48
Indivior
INDV
$3.08B
| $1.83M | 0.68% |
142,634
| – | – |
|
49
Alibaba
BABA
$325B
| $1.77M | 0.66% |
20,857
+500
| +2% | +$42.4K |
|
50
Cisco
CSCO
$268B
| $1.75M | 0.65% |
29,600
-2,300
| -7% | -$136K |
|